The Food and Drug Administration has approved pimavanserin for the indication of hallucinations and delusions associated with psychosis in Parkinson’s disease.
Patients with rosacea, particularly those older than 60, have an increased risk of being diagnosed with dementia and Alzheimer’s disease, according to Alexander Egeberg, MD, PhD, and his associates. Their findings are published in the Annals of...
Antibiotic use may drive Clostridium difficile transmission within long-term care facilities, according to the results of a recent study published in Annals of Internal Medicine.
Screening asymptomatic patients admitted through the ED for occult Clostridium difficile infection, then isolating those found to be carriers throughout their hospital stay, substantially reduced the incidence of hospital-acquired C. difficile...
AMSTERDAM — Clostridium difficile infections are a major driver of death and nursing home placement in Americans older than 65, according to research presented at a major international conference on infectious diseases.
VANCOUVER — An extended-release amantadine formulation reduced levodopa-induced dyskinesia in a phase III Parkinson’s disease trial from the drug’s developer, Adamas Pharmaceuticals.
Yes, you read that correctly. Historically, I’ve been the kind of curmudgeon who grumbles constantly about how governmental agencies like the Centers for Medicare & Medicaid Services have no clue about what’s really going on, how they have their...
ORLANDO, FL — A panel of experts presented several pearls and strategies to begin “rational deprescribing” to combat polypharmacy in nursing home residents. Ariel Cole, MD, CMD, described a typical scenario for a new admission during a session at...
ORLANDO, FL — Caring for the Ages Editor in Chief Karl Steinberg, MD, CMD, HMDC, and other Society leaders led an audience through a sometimes mystifying maze of policy issues that affect practice and reimbursement, here at the Society’s Annual...
